Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 1.850

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Norm Demers	10/21/2005 8:48:24 AM
	of 428

NVAX upgraded. Friday , October 21, 2005 07:51 ET Issuer: Novavax, Inc. (NasdaqNM: NVAX) Analyst Firm: RBC Capital Markets Ratings Action: UPGRADE Current Rating: Sector Perform (from Underperform) Analyst Comments: The firm based their upgrade on recently announced license and supply agreement with Esprit Pharma for NVAX's Estrasorb, a topical estrogen therapy. They think the deal was essential to NVAX because it provides the company with much needed capital.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next